These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 20224643)

  • 21. The Complex Role of Infectious Agents in Human Cutaneous T-Cell Lymphoma Pathogenesis: From Candidate Etiological Factors to Potential Therapeutics.
    Angelova A; Rommelaere J; Ungerechts G
    Pathogens; 2024 Feb; 13(3):. PubMed ID: 38535528
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oncolytic Virus-Bearing Neural Stem Cells Safe in High-Grade Glioma.
    Cancer Discov; 2021 Sep; 11(9):2123. PubMed ID: 34244213
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oncolytic H-1 Parvovirus Shows Safety and Signs of Immunogenic Activity in a First Phase I/IIa Glioblastoma Trial.
    Geletneky K; Hajda J; Angelova AL; Leuchs B; Capper D; Bartsch AJ; Neumann JO; Schöning T; Hüsing J; Beelte B; Kiprianova I; Roscher M; Bhat R; von Deimling A; Brück W; Just A; Frehtman V; Löbhard S; Terletskaia-Ladwig E; Fry J; Jochims K; Daniel V; Krebs O; Dahm M; Huber B; Unterberg A; Rommelaere J
    Mol Ther; 2017 Dec; 25(12):2620-2634. PubMed ID: 28967558
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase I/IIa study of intratumoral/intracerebral or intravenous/intracerebral administration of Parvovirus H-1 (ParvOryx) in patients with progressive primary or recurrent glioblastoma multiforme: ParvOryx01 protocol.
    Geletneky K; Huesing J; Rommelaere J; Schlehofer JR; Leuchs B; Dahm M; Krebs O; von Knebel Doeberitz M; Huber B; Hajda J
    BMC Cancer; 2012 Mar; 12():99. PubMed ID: 22436661
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regression of advanced rat and human gliomas by local or systemic treatment with oncolytic parvovirus H-1 in rat models.
    Geletneky K; Kiprianova I; Ayache A; Koch R; Herrero Y Calle M; Deleu L; Sommer C; Thomas N; Rommelaere J; Schlehofer JR
    Neuro Oncol; 2010 Aug; 12(8):804-14. PubMed ID: 20299703
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel Therapies in Glioblastoma Treatment: Review of Glioblastoma; Current Treatment Options; and Novel Oncolytic Viral Therapies.
    Shah S
    Med Sci (Basel); 2023 Dec; 12(1):. PubMed ID: 38249077
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent Developments in Glioblastoma Therapy: Oncolytic Viruses and Emerging Future Strategies.
    Hamad A; Yusubalieva GM; Baklaushev VP; Chumakov PM; Lipatova AV
    Viruses; 2023 Feb; 15(2):. PubMed ID: 36851761
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advances in immunotherapy for glioblastoma multiforme.
    Mahmoud AB; Ajina R; Aref S; Darwish M; Alsayb M; Taher M; AlSharif SA; Hashem AM; Alkayyal AA
    Front Immunol; 2022; 13():944452. PubMed ID: 36311781
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro Characterization of Enhanced Human Immune Responses by GM-CSF Encoding HSV-1-Induced Melanoma Cells.
    Delic M; Boeswald V; Goepfert K; Pabst P; Moehler M
    Onco Targets Ther; 2022; 15():1291-1307. PubMed ID: 36310770
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oncolytic Virus-Induced Autophagy in Glioblastoma.
    Kamynina M; Tskhovrebova S; Fares J; Timashev P; Laevskaya A; Ulasov I
    Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298694
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Perspective of mesenchymal transformation in glioblastoma.
    Kim Y; Varn FS; Park SH; Yoon BW; Park HR; Lee C; Verhaak RGW; Paek SH
    Acta Neuropathol Commun; 2021 Mar; 9(1):50. PubMed ID: 33762019
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Parvovirus-Based Combinatorial Immunotherapy: A Reinforced Therapeutic Strategy against Poor-Prognosis Solid Cancers.
    Angelova A; Ferreira T; Bretscher C; Rommelaere J; Marchini A
    Cancers (Basel); 2021 Jan; 13(2):. PubMed ID: 33477757
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unique challenges for glioblastoma immunotherapy-discussions across neuro-oncology and non-neuro-oncology experts in cancer immunology. Meeting Report from the 2019 SNO Immuno-Oncology Think Tank.
    Chuntova P; Chow F; Watchmaker PB; Galvez M; Heimberger AB; Newell EW; Diaz A; DePinho RA; Li MO; Wherry EJ; Mitchell D; Terabe M; Wainwright DA; Berzofsky JA; Herold-Mende C; Heath JR; Lim M; Margolin KA; Chiocca EA; Kasahara N; Ellingson BM; Brown CE; Chen Y; Fecci PE; Reardon DA; Dunn GP; Liau LM; Costello JF; Wick W; Cloughesy T; Timmer WC; Wen PY; Prins RM; Platten M; Okada H
    Neuro Oncol; 2021 Mar; 23(3):356-375. PubMed ID: 33367885
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oncolytic Virotherapy in Glioma Tumors.
    Rius-Rocabert S; García-Romero N; García A; Ayuso-Sacido A; Nistal-Villan E
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33066689
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cancer Treatment Goes Viral: Using Viral Proteins to Induce Tumour-Specific Cell Death.
    Wyatt J; Müller MM; Tavassoli M
    Cancers (Basel); 2019 Dec; 11(12):. PubMed ID: 31817939
    [TBL] [Abstract][Full Text] [Related]  

  • 36. H-1 Parvovirus as a Cancer-Killing Agent: Past, Present, and Future.
    Bretscher C; Marchini A
    Viruses; 2019 Jun; 11(6):. PubMed ID: 31216641
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Virus-Based Immunotherapy of Glioblastoma.
    Martikainen M; Essand M
    Cancers (Basel); 2019 Feb; 11(2):. PubMed ID: 30764570
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Oncolytic Virotherapy Era in Cancer Management: Prospects of Applying H-1 Parvovirus to Treat Blood and Solid Cancers.
    Angelova AL; Witzens-Harig M; Galabov AS; Rommelaere J
    Front Oncol; 2017; 7():93. PubMed ID: 28553616
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oncolytic parvoviruses: from basic virology to clinical applications.
    Marchini A; Bonifati S; Scott EM; Angelova AL; Rommelaere J
    Virol J; 2015 Jan; 12():6. PubMed ID: 25630937
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oncolytic Viruses to Treat Ovarian Cancer Patients - a Review of Results From Clinical Trials.
    Hartkopf AD; Fehm T; Wallwiener M; Lauer U
    Geburtshilfe Frauenheilkd; 2012 Feb; 72(2):132-136. PubMed ID: 25374430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.